Stock Rating Downgrade
The Value Trend Rating for Pfizer Inc (NYSE: PFE) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Pfizer Inc (NYSE: PFE) stock rose slightly by 0.1% on 3/1/24. The stock closed at $26.59. This advance was accompanied by normal trading volume. Relative to the market the stock has been weak over the last nine months and has declined -3.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, PFE is expected to continue to be a major Value Builder.
Pfizer has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Pfizer has a good Appreciation Score of 77 but a very low Power Rating of 9, with the Negative Value Trend Rating the result.
Be the first to comment